৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬


Products
Payment
Delivery
Hypertension, Oedema
Should be taken with food. Take after meals.
Hypertension\r\n1-2 tablets/capsules (37.5-50 mg triamterene and 25 mg HCTZ) PO qDay\r\n\r\n1 tablet (75 mg triamterene and 50 mg HCTZ) PO qDay\r\n\r\nDosing considerations\r\nMonitor serum potassium\r\nEdema\r\n1-2 tablets/capsules (37.5-50 mg triamterene and 25 mg HCTZ) PO qDay\r\n\r\n1 tablet (75 mg triamterene and 50 mg HCTZ) PO qDay
Safety and efficacy not established
severe renal or hepatic impairment, preexisting or drug-induced hyperkalemia, patients at risk of respiratory or metabolic acidosis. Lactation.
Hydrochlorothiazide inhibits the reabsorption of Na and chloride in the distal tubules causing increased excretion of Na and water K and hydrogen ions.\r\n\r\nTriamterene is a potassium sparing diuretic which appears to act mainly on the distal renal tubules. It increases the excretion of Na and reduces the excretion of potassium. It adds to the natriuretic but reduces the kaliuretic effects of other diuretics. It is structurally similar to folate and has anti-folate activity.
Renal and hepatic impairment; cirrhosis; DM; hyponatraemia; hyperuricaemia; history of nephrolithiasis; depleted folic acid stores. Monitor electrolyte concentrations closely, especially potassium levels. Observe for signs of liver damage, blood dyscrasias or other idiosyncratic reactions. Discontinue treatment if urinary calculus is passed. Pregnancy and elderly.\r\n\r\nLactation: Not recommended; discontinue drug or do not nurse
Triamterene\r\nJaundice,Weaknes,Headache,Azotemia,Dizziness,Fatigue,Xerostomia,Photosensitivity,Rash,Diarrhea,Nausea,Vomiting,Hyperuricemia,Hyper/hypokalemia,Interstitial nephritis\r\n\r\nHydrochlorothiazide\r\nAnorexia,Epigastric distress,Hypotension,Orthostatic hypotension,Photosensitivity,Anaphylaxis,Anemia,Confusion,Erythema multiforme,Stevens-Johnson syndrome,Exfoliative dermatitis including toxic epidermal necrolysis,Dizziness,Hypokalemia and/or hypomagnesemia,Hyperuricemia\r\n
May enhance toxicity of digitalis glycosides, neuromuscular-blocking action of competitive muscle relaxants, effect of antihypertensives. Increased risk of postural hypotension w/ alcohol, barbiturates, opioids. K-depleting effect enhanced by corticosteroids, lithium, ACTH, carbenoxolone.
Hypertension, Oedema
Should be taken with food. Take after meals.
Hypertension\r\n1-2 tablets/capsules (37.5-50 mg triamterene and 25 mg HCTZ) PO qDay\r\n\r\n1 tablet (75 mg triamterene and 50 mg HCTZ) PO qDay\r\n\r\nDosing considerations\r\nMonitor serum potassium\r\nEdema\r\n1-2 tablets/capsules (37.5-50 mg triamterene and 25 mg HCTZ) PO qDay\r\n\r\n1 tablet (75 mg triamterene and 50 mg HCTZ) PO qDay
Safety and efficacy not established
severe renal or hepatic impairment, preexisting or drug-induced hyperkalemia, patients at risk of respiratory or metabolic acidosis. Lactation.
Hydrochlorothiazide inhibits the reabsorption of Na and chloride in the distal tubules causing increased excretion of Na and water K and hydrogen ions.\r\n\r\nTriamterene is a potassium sparing diuretic which appears to act mainly on the distal renal tubules. It increases the excretion of Na and reduces the excretion of potassium. It adds to the natriuretic but reduces the kaliuretic effects of other diuretics. It is structurally similar to folate and has anti-folate activity.
Renal and hepatic impairment; cirrhosis; DM; hyponatraemia; hyperuricaemia; history of nephrolithiasis; depleted folic acid stores. Monitor electrolyte concentrations closely, especially potassium levels. Observe for signs of liver damage, blood dyscrasias or other idiosyncratic reactions. Discontinue treatment if urinary calculus is passed. Pregnancy and elderly.\r\n\r\nLactation: Not recommended; discontinue drug or do not nurse
Triamterene\r\nJaundice,Weaknes,Headache,Azotemia,Dizziness,Fatigue,Xerostomia,Photosensitivity,Rash,Diarrhea,Nausea,Vomiting,Hyperuricemia,Hyper/hypokalemia,Interstitial nephritis\r\n\r\nHydrochlorothiazide\r\nAnorexia,Epigastric distress,Hypotension,Orthostatic hypotension,Photosensitivity,Anaphylaxis,Anemia,Confusion,Erythema multiforme,Stevens-Johnson syndrome,Exfoliative dermatitis including toxic epidermal necrolysis,Dizziness,Hypokalemia and/or hypomagnesemia,Hyperuricemia\r\n
May enhance toxicity of digitalis glycosides, neuromuscular-blocking action of competitive muscle relaxants, effect of antihypertensives. Increased risk of postural hypotension w/ alcohol, barbiturates, opioids. K-depleting effect enhanced by corticosteroids, lithium, ACTH, carbenoxolone.






N/A





